A B S T R A C T Heparin as measured by azure A metachromasia and anticoagulant activity has been extracted with 1 M NaCl from 35S-labeled human lung fragments or dispersed human lung cells enriched for mast cells. The 35S-labeled metachromatic material in the 3 M NaCl eluate from Dowex-1 chromatography of the extract from lung fragments exhibited an average mol wt of 20,000 by Sepharose 4B gel filtration. The 35S-labeled metachromatic material with the charge characteristics of commercial porcine heparin on DEAE cellulose chromatography was entirely heparin by the criteria of resistance to degradation by chondroitin ABC lyase and complete degradation by purified heparinase. Antithrombin affinity chromatography of purified heparin with an anticoagulant activity of 137 U/mg, revealed that the one-third that was bound and eluted had a 273 U/mg sp act, whereas the unbound activity was 31 U/mg. Thus, the previously observed heterogeneity of commercial porcine heparin for binding to human antithrombin was also observed with human heparin. The mast cell-enriched human lung cell preparations yielded [35S]mucopolysaccharides with an average mol wt of 60,000 by Sepharose 4B gel filtration. Approximately
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Human tissue heparin-like activity, defined only by the presence of anticoagulant function and metachromasia, has been observed in mucopolysaccharidecontaining fractions extracted from lung (6, 7), liver (8) , skin (9) , and blood (10, 11) . However, in no instance has the material been assessed for binding to human antithrombin. In the present studies, human lung heparin was isolated and defined by anticoagulant activity, azure A metachromasia, susceptibility to degradation by purified heparinase, and resistance to degradation by chondroitin ABC lyase. The human heparin purified from lung fragments had an average mol wt of 20,000 and approximately one-third bound to human antithrombin, a result analogous to the binding heterogeneity observed with porcine heparin. In addition, heparin with an average mol wt of60,000 was isolated from dispersed enriched populations ofhuman lung mast cells and shown to be composed of 20 (17) . During extraction and purification procedures heparin was estimated by change in adsorbance at 510 after formation of a heparin-azure A metachromatic complex with commercial porcine heparin as a standard (18, 19) . It required [25] [26] [27] [28] [29] [30] (21) .
To obtain mast cells, the human lung fragments were enzymatically digested in a four-step procedure with chymopapain, pronase, collagenase, and elastase (22, 23) . The dispersed cells obtained at each step were pooled, and the mast cells were concentrated to 40-70% purity by isopyknic and velocity gradient sedimentation (24, 25) . The purity was defined by phase microscopy after staining with toluidine blue (26) and by electron microscopy (25) . The mast cell-rich cell suspension at a concentration of 5 x 106_ 1 x 107 cells/ml was incubated in Eagle's basal medium with Hanks' balanced salt solution with 0.1 mCi [p5Ssulfate in a final vol of 5-10 ml for 18 h at 37°C under 5.0% CO2 tension, washed three times in Tyrode's solution, and extracted by freeze-thawing six times in 1 M NaCl.
RESULTS
Isolation and purification of heparin from human lung fragments. The extracts from 55, 82, and 200 g of human lung fragments, designated preparations 1, 2, and 3, respectively, were each applied directly to a 2 x 20-cm column of Dowex-1 equilibrated in 1 M NaCl and eluted in stepwise fashion with 1, 3, and 4 M NaCl (2, 27) . Portions of each fraction were assessed for 3S, protein (28) , uronic acid, metachromasia, and anticoagulant activity. The 1 M NaCl effluent contained more than 99% of 35S, histamine, and total protein, but was without azure A metachromasia and anticoagulant activity. The material eluted by 3 M NaCl contained uronic acid, <0.1% of the total protein, <0.003% of the 35S, and exhibited all of the azure A metachromasia and anticoagulant activity. Based upon metachromasia, the heparin content in the 3 M NaCl extract from the three separate lung fragment preparations was 4.5,22.5, and 44.7 ,ug/g lung tissue. Histamine content in the 1 M NaCl effluent in the same three lung preparations was 2, 8, and 20 ,ug/g lung tissue. The 4 M NaCl eluate had minimal 35S and no metachromasia or anticoagulant activity. Treatment of residual lung fragments with 4 M guanidinium chloride and 0.5 M NaOH failed to yield additional azure A-positive material but did free additional uronic acid-containing materials. A portion of the 3 M NaCl eluates from Dowex-1 obtained from the three different lung preparations and containing 140, 920, and 4,474 ,ug of heparin by metachromasia, respectively, was filtered in 2 M NaCl on a 1 x 60-cm column of Sepharose 4B at a flow rate of 2 ml/h. 1-ml fractions were collected, and portions were assayed for 35S, uronic acid, anticoagulant activity, and metachromasia. Heparin, as determined by metachromasia, filtered as a single broad peak, with an estimated average mol wt of 20,000 (Fig. 1) activity but less endogenous heparin in the lung extract. A sample from preparation 1 containing 800 cpm and with a 12 cpm/,ug heparin sp act by azure A metachromasia was incubated with 250 ,ug ofpurified heparinase for 90 min in 0.1 ml of 0.1 M acetate buffer, pH 7.0, at 30°C, and a replicate sample was incubated in buffer alone. Degradation was assessed by filtration on a 1 x 60-cm column of Sephadex G-50 equilibrated in H20 with a flow rate of 2.5 ml/h, and 1-ml fractions were collected. More than 70% of the heparinasetreated material was degraded when compared to the untreated sample (Fig. 3) . This pattern is similar to that obtained when 250 jig of commercial heparin was treated in the same fashion.
To isolate the heparin directly, a portion of the 3 M NaCl eluate from Dowex-1 chromatography of preparation 3 containing 2,092 jug of heparin as defined by metachromasia was applied to a 1 x 5-cm column of DEAE-cellulose equilibrated in 0.01 M sodium acetate buffer with 0.1 M LiCl, pH 5.5. The column was eluted with a logarithmic gradient from 0.1 to 1.0 M LiCl, followed by a second logarithmic gradient from 1.0 to 2.0 M LiCl (30) . Fractions of 2 ml each were collected at a flow rate of [25] [26] [27] [28] [29] [30] metachromasia (Fig. 4) -0.1-1.011 LiCI Grodient---.0-2.0M LiCI Grodient-FRACTION NUMBER FIGURE 4 DEAE-cellulose chromatography of human lung fragment mucopolysaccharides from preparation 3 contained in the 3 M NaCl eluate from Dowex-1 chromatography. Determinations in every other tube are shown. The column was previously standardized with chondroitin 4-sulfate (3 mg), commercial heparin (3 mg), and hyaluronic acid (2 mg).
each incubated with 1 U of chondroitin ABC lyase in enriched Tris buffer for 90 min at 37°C. Sephadex G-50 gel filtration of treated and untreated material, performed as described for Fig. 2 , showed that 90% of the [35S]mucopolysaccharides from fractions 47-75 were degraded, whereas none was degraded in the pool from fractions 87-111. Based on azure A metachromasia, the specific activity of the heparin in the latter was 4.3 cpm/,ug. This material was completely degraded by heparinase under the conditions described for Fig. 3 . The total recovery of heparin after Sepharose 4B gel filtration of the original 3 M NaCl Dowex-1 eluate was 75-90% for three human lung preparations as defined by the chondroitin ABC lyase-resistant, heparinasesensitive, azure A-positive material, and 70 and 74% in two preparations obtained by DEAE cellulose chromatography and defined by azure A metachromasia.
Specific anticoagulant activity and affinity for antithrombin. The heparin in the azure A-positive peak fractions 87-111 (Fig. 4) was divided into five 5-ml pools consisting of 1 ml from each of fractions 87-91, 92-96, 97-101, 102-106, and 107-111. After dialysis and lyophilization, each pool was assayed for heparin by uronic acid, radioactivity and anticoagulant activity (Table I) . Specific anticoagulant activity increased sequentially in the five pools from 27 U/mg to 179 U/mg when compared to a heparin standard of known U. S. Pharmacopeia potency (4), while the specific radioactivity of [35S]heparin/mg was highest in pool 1 (Table I) . Pools 1 and 2 with the lowest functional activity, and pools [3] [4] [5] with the highest functional activity were separately combined (Table II) . Each composite pool was applied to 1 x 2-cm Sepharose-antithrombin column equilibrated in 0.1 M NaCl. The columns were washed with three bed volumes ofequilibrating buffer, and eluted with 1 M NaCl. Approximately 19% of the heparin defined by uronic acid content in pools [1] [2] bound to the antithrombin. After elution with 1 M NaCl it had a sp act of 187 U/mg heparin as compared to 8 U/mg heparin for the material that failed to bind. Approximately 33% of the heparin defined by uronic acid content in pools 3-5 bound to the antithrombin and had a specific activity of273 U/mg heparin, whereas 31 U/mg heparin was recovered in material that failed to bind. The material in the wash between the collection of unbound and bound heparin was not quantitated because of dilution and it is assumed that this accounts for the loss of _20% of the material applied. Heparin in mast cell-enriched cell suspensions. The extracts from three different preparations of 35S-labeled dispersed human lung cells of 40-70% mast cell purity and containing 5.0, 6.4, and 8.0 x 106 mast cells were chromatographed over Dowex-1 in a manner identical to that used to separate human lung fragment mucopolysaccharides from histamine, protein, and free 35S. In contrast, the 3 M NaCl Dowex-1 eluate from 2.6 x 106 lung cells consisting of <4% mast cells, had no detectable metachromasia and the 1 M NaCl Dowex-1 effluent had no measurable histamine. The entire 3 M NaCI Dowex-1 eluate of each of the three mast cell preparations was filtered separately in 2 M NaCl on a 1 x 60-cm column ofSepharose 4B at a flow rate of2 ml/h and 1-ml fractions were assayed for 35S. There was insufficient material to assay fractions by uronic acid content or metachromasia. As shown in Fig. 5A (Fig. 5B ) that more than 70% was resistant to degradation by chondroitin ABC lyase, and the remainder appeared in a second peak of glycosaminoglycan degradation products. Chondroitin ABC lyase-resistant material in fractions [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] (Fig. 5B) was pooled, dialyzed, and lyophilized. One-third was subjected to f-elimination with 0.5 M NaOH and another one-third to degradation with heparinase. When the portion treated with 0.5 M NaOH for 14 h at 22°C was rechromatographed on the same Sepharose 4B column, a predominant peak containing 74% of the [5S]mucopolysaccharide filtered with an approximate mol wt of 20,000, followed by a peak of lower molecular weight. The second one-third was mixed with 250 ,g ofcommercial heparin in 0.1 ml of 0.1 M Na acetate buffer, pH 7.0, filtered on a 1 x 60-cm column of Sephadex G-50 in distilled H20 at a flow rate of 2.5 ml/h, and fractions of 0.67 ml collected. pended in 0.1 ml of the above buffer and incuibated with 250 ,tg of purified heparinase for 90 min at 30°C. Chromatography of this reaction mixture showed that the 35S-labeled mucopolysaccharide was degraded when compared to untreated material (Fig. 6) . The 250 ,ug of commercial heparin added as an internal standard was also degraded as assessed by a shift ofthe uronic acid from the excluded to the included fractions.
DISCUSSION
Human heparin, previously recognized only on the basis of metachromasia and anticoagulant activity (6-11), has been isolated from human lung and characterized in terms of size, charge, enzyme susceptibility, and specific functional activity. Human lung fragments were labeled with 35S and extracted in 1 M NaCl, and the [35S]mucopolysaccharides were separated from free counts and protein by chromatography on Dowex-1. The metachromatic material in the 3 M eluate fraction exhibited an average mol wt of 20,000 by Sepharose 4B gel filtration (Fig. 1) and the charge characteristics of commercial heparin on DEAE cellulose chromatography (Fig. 4) . The glycosaminoglycan heparin isolated by DEAE cellulose chromatography was free of contaminating glycosaminoglycans, as there was no degradation by chondroitin ABC lyase and full degradation of the material by purified heparinase. When two DEAE fractions of this human heparin were subjected to antithrombinaffinity chromatography, the bound and eluted material exhibited a specific anticoagulant activity of 187 and 273 U/mg, whereas the unbound material had an activity of only 8 and 31 U/mg, respectively (Table II) . Hence the partitioning of heparin on antithrombin cannot be ascribed to lack of species concordance.
To demonstrate that heparin was associated with mast cells, human lung fragments were enzymatically digested and the dispersed mast cells were concentrated to 40-70% (25) . The [35S]mucopolysaccharides extracted in 1 M NaCl and eluting from Dowex-1 in 3 M NaCl exhibited an average mol wt of 60,000 by Sepharose 4B gel filtration (Fig. 5A ). Approximately 30% of this fraction was degraded by treatment with chondroitin ABC lyase (Fig. SB) , and the residual 70% was susceptible to degradation by purified heparinase (Fig. 6) . As the degradation ofheparitin sulfates by purified heparinase during two sequential 24-h digestions yields almost entirely products excluded on Sephadex G-50 (31), the degradation in 1.5 h to products that are entirely included on Sephadex G-50 gel filtration indicates that the chondroitin ABC lyase-resistant sulfated mucopolysaccharide was entirely heparin. When the chondroitin ABC lyase-resistant material was subjected to alkali treatment under conditions known to cleave xylosyl-seryl linkages in proteoglycans, the predominant radiolabeled peak was reduced to an estimated average mol wt of 20,000. This fact suggests that the mast cell-enriched preparations contain a small proteoglycan with an average mol wt of 60,000 and that the glycosaminoglycan side chains were similar in size to those isolated directly from the human lung fragments. The ratio of histamine to heparin by weight was 1:2.2, 1:2.9, and 1:2.2 for the three human lung fragment preparations and 1:1.9, 1:2.2, and 1:3.1 for the three preparations of dispersed lung cells obtained from additional lung specimens. Since the mast cell is the only defined source of lung histamine, the consistency in these ratios suggests that heparin was derived from the same cell. Basophils have not been observed by electron microscopic examination of dispersed human lung cells, or in the mast cell-enriched preparations (25) ; further, heparin is not a major mucopolysaccharide of this cell, being absent in guinea-pig basophils (32) and consisting of <20% of the mucopolysaccharide obtained from human or rat leukemic basophils (33, 34) . The content of histamine in human lung mast cells ranged from 1.0 to 2.8 ,g/106 cells, as observed previously (25) , and of heparin from 2.4 to 7.8 ,g/106 cells.
